Abstract

Three-dimensional (3D) cell culture technology captures the market! Driving forces include an increase in cancer worldwide, but also reinforced research for biopharmaceutical products to cure diseases and to reduce animal experiments. The challenge now is to translate in vitro assays into relevant in vivo outcomes. At the TEDD Annual Meeting, selected experts explored this problem and discussed how to move 3D cell cultures from bench to practice.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call